3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Hematologic Diseases
1
Bone Marrow Diseases
1
Interventions
Specimen Handling
64
Magnetic Resonance Spectroscopy
44
Carboplatin
34
Cyclophosphamide
31
Gemcitabine
29
Biopsy
28
Cisplatin
27
Radiotherapy
26
pembrolizumab
25
Bevacizumab
25
Paclitaxel
23
Standard of Care
22
Oxaliplatin
22
Drug Therapy
22
venetoclax
21
Nivolumab
21
Capecitabine
21
fludarabine
20
Injections
20
Interviews as Topic
18
Radiosurgery
16
Dexamethasone
16
Blood Specimen Collection
16
Azacitidine
16
toripalimab
15
tislelizumab
14
cemiplimab
13
anlotinib
13
Irinotecan
13
Pemetrexed
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Clinical Laboratory Techniques
×
90 days
×
Clear all
NCT07387354
2026-03-16
MDS
Thomas Jefferson University
Phase 1/2
Not yet recruiting
25 enrolled